Faculty Opinions recommendation of Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: design, synthesis, and preclinical characterization.

Author(s):  
Thomas W von Geldern
Sign in / Sign up

Export Citation Format

Share Document